Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Skye Bioscience, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Skye Bioscience, Inc. is a clinical-stage pharmaceutical company developing cannabinoid-based therapies. The company focuses on treating metabolic diseases such as obesity and related metabolic disorders. Skye is advancing its lead compound through clinical trials for various indications.